Home Kadmon

Kadmon

acquired
Post-IPO Round
Biopharmaceutical Manufacturer
Basic
Enterprise Profile

Basic Information

Kadmon Corporation is a biopharmaceutical company that provides products and services for the treatment and management of hepatitis C, offering a variety of services and programs to support patients, prescribers, and pharmacies. Our clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies, including a patient assistance program that provides free medication to patients with limited or no insurance.
Kadmon Corporation, LLC
NewYork,NewYork,United States of America
101~500 people
January 01, 2009
david@argotpartners.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Gene Technology Biotechnology
Concept
Tumor Immune System Diseases Therapeutic Products
Application Scenarios
Biologics Innovative Drugs